Human/JJ
T/NN
cell/NN
activation/NN
through/IN
the/DT
activation-inducer/JJ
molecule/CD69/NN
enhances/VBZ
the/DT
activity/NN
of/IN
transcription/NN
factor/NN
AP-1/NN
./.

The/DT
induction/NN
of/IN
the/DT
AP-1/NN
transcription/NN
factor/NN
has/VBZ
been/VBN
ascribed/VBN
to/TO
the/DT
early/JJ
events/NNS
leading/VBG
to/TO
T/NN
cell/NN
differentiation/NN
and/CC
activation/NN
./.
=====
We/PRP
have/VBP
studied/VBN
the/DT
regulation/NN
of/IN
AP-1/NN
activity/NN
in/IN
human/JJ
peripheral/JJ
blood/NN
T/NN
lymphocytes/NNS
stimulated/VBN
through/IN
the/DT
activation/NN
inducer/NN
molecule/NN
(/(
AIM/NN
)/)
/CD69/NN
activation/NN
pathway/NN
./.
=====
Phorbol/NN
esters/NNS
are/VBP
required/VBN
to/TO
induce/VB
AIM/CD69/NN
cell-surface/JJ
expression/NN
as/RB
well/RB
as/IN
for/IN
triggering/VBG
the/DT
proliferation/NN
of/IN
T/NN
cells/NNS
in/IN
conjunction/NN
with/IN
anti-AIM/JJ
mAb/NN
./.
=====
Mobility/NN
shift/NN
assays/NNS
showed/VBD
that/IN
addition/NN
of/IN
anti-AIM/JJ
mAb/NN
to/TO
PMA-treated/JJ
T/NN
lymphocytes/NNS
markedly/RB
enhanced/VBD
the/DT
binding/NN
activity/NN
of/IN
AP-1/NN
to/TO
its/PRP$
cognate/JJ
sequence/NN
,/,
the/DT
phorbol/NN
ester/NN
response/NN
element/NN
./.
=====
In/IN
contrast/NN
,/,
anti-AIM/NN
mAb/NN
did/VBD
not/RB
induce/VB
any/DT
change/NN
in/IN
the/DT
binding/NN
activity/NN
of/IN
NF-kappa/NN
B/NN
,/,
a/DT
transcription/NN
factor/NN
whose/WP$
activity/NN
is/VBZ
also/RB
regulated/VBN
by/IN
protein/NN
kinase/NN
C/NN
./.
=====
The/DT
increase/NN
in/IN
AP-1-binding/JJ
activity/NN
was/VBD
accompanied/VBN
by/IN
the/DT
marked/JJ
stimulation/NN
of/IN
the/DT
transcription/NN
of/IN
c-fos/NN
but/CC
not/RB
that/DT
of/IN
c-jun/NN
./.
=====
Blockade/NN
of/IN
the/DT
DNA-binding/JJ
complexes/NNS
with/IN
an/DT
anti-Fos/JJ
mAb/NN
demonstrated/VBD
a/DT
direct/JJ
participation/NN
of/IN
c-Fos/NN
in/IN
the/DT
AP-1/NN
complexes/NNS
induced/VBN
by/IN
anti-AIM/NN
mAb/NN
./.
=====
Most/JJS
of/IN
the/DT
AP-1/NN
activity/NN
could/MD
be/VB
eliminated/VBN
when/WRB
the/DT
anti-AIM/NN
mAb/NN
was/VBD
added/VBN
to/TO
the/DT
culture/NN
medium/NN
in/IN
the/DT
presence/NN
of/IN
cycloheximide/NN
,/,
suggesting/VBG
that/IN
de/FW
novo/FW
protein/NN
synthesis/NN
is/VBZ
crucial/JJ
for/IN
the/DT
induction/NN
of/IN
AP-1-binding/JJ
activity/NN
./.
=====
These/DT
data/NNS
provide/VBP
the/DT
evidence/NN
that/IN
activation/NN
of/IN
human/JJ
peripheral/JJ
blood/NN
T/NN
cells/NNS
through/IN
the/DT
AIM/NN
activation/NN
pathway/NN
regulate/VBP
the/DT
activity/NN
of/IN
AP-1/NN
./.
=====
Therefore/RB
,/,
this/DT
pathway/NN
appears/VBZ
as/IN
a/DT
crucial/JJ
step/NN
in/IN
the/DT
initiation/NN
of/IN
early/JJ
T/NN
cell/NN
activation/NN
events/NNS
./.